Ashina, M., Goadsby, P. J., Reuter, U., Silberstein, S., Dodick, D. W., Xue, F., . . . Mikol, D. D. (2021). Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial. European journal of neurology, 28(5), 1716-1725. https://doi.org/10.1111/ene.14715
Chicago-Zitierstil (17. Ausg.)Ashina, Messoud, et al. "Long‐term Efficacy and Safety of Erenumab in Migraine Prevention: Results from a 5‐year, Open‐label Treatment Phase of a Randomized Clinical Trial." European Journal of Neurology 28, no. 5 (2021): 1716-1725. https://doi.org/10.1111/ene.14715.
MLA-Zitierstil (9. Ausg.)Ashina, Messoud, et al. "Long‐term Efficacy and Safety of Erenumab in Migraine Prevention: Results from a 5‐year, Open‐label Treatment Phase of a Randomized Clinical Trial." European Journal of Neurology, vol. 28, no. 5, 2021, pp. 1716-1725, https://doi.org/10.1111/ene.14715.